The presence in DPSCs of the GSK3β, known to phosphorylate tau (68), and the APP, the source of toxic amyloid peptides, enhancing this kinase activity to the level of hyperphosphorylation and formation of NFTs in AD (69–71). This evidence concerns the gene MAPT and Alzheimer disease.